急性細菌性結膜炎に対する抗菌薬の有益性と有害性は何か? https://t.co/GAcRF05ktd
RT @CochraneFrance: 👀Quels sont les bénéfices et les risques des antibiotiques dans le traitement de la conjonctivite bactérienne aiguë ?…
👀Quels sont les bénéfices et les risques des antibiotiques dans le traitement de la conjonctivite bactérienne aiguë ? ➡️Revue @CochraneEyes évaluant 21 ECR avec 8805 participants 📚Résumé disponible sur @CochraneLibrary 🔗https://t.co/rA2aTGLhkJ https://t.
RT @CochraneEyes: Read our updated #Cochrane Review on Antibiotics versus placebo for acute bacterial #conjunctivitis https://t.co/Jgt0hUO…
RT @CochraneEyes: Read our updated #Cochrane Review on Antibiotics versus placebo for acute bacterial #conjunctivitis https://t.co/Jgt0hUO…
RT @CochraneEyes: Read our updated #Cochrane Review on Antibiotics versus placebo for acute bacterial #conjunctivitis https://t.co/Jgt0hUO…
Read our updated #Cochrane Review on Antibiotics versus placebo for acute bacterial #conjunctivitis https://t.co/Jgt0hUOHKQ https://t.co/ZA6zehpkSw
Antibiotics versus placebo for acute bacterial conjunctivitis https://t.co/i1AHL2lffr
RT @reverendofdoubt: Interesting @cochranecollab #SRMAs recently published: 1. Abx vs placebo for bacterial conjunctivitis: https://t.co/5b…
Interesting @cochranecollab #SRMAs recently published: 1. Abx vs placebo for bacterial conjunctivitis: https://t.co/5bsddSPEyb 2. We still don't know how to prevent geriatric falls: https://t.co/26ATrxJ5MK 3. Meds don't work for traumatic hyphema: https://
RT @3stars67664378: 細菌性結膜炎に対する👁️抗菌薬点眼 - 📘SRMA - 抗菌薬点眼は臨床治癒を有意に改善 (RR 1.26, 95% CI 1.09 to 1.46; 5 trials, 1474 participants; moderate certa…
細菌性結膜炎に対する👁️抗菌薬点眼 - 📘SRMA - 抗菌薬点眼は臨床治癒を有意に改善 (RR 1.26, 95% CI 1.09 to 1.46; 5 trials, 1474 participants; moderate certainty)
【コクランレビュー】急性細菌性結膜炎に対する抗菌薬対プラセボ(抗菌薬の点眼薬または眼軟膏はプラセボと比較して臨床的治癒を改善させるかもしれない。) #ペ読 https://t.co/epBeytxLMn
Antibiotics versus placebo for acute bacterial conjunctivitis - Chen, Y-Y - 2023 | Cochrane Library https://t.co/EDe3NT3HyT #Cochrane_Update